Literature DB >> 21386042

Initial mean length of utterance predicts the relative efficacy of two grammatical treatments in preschoolers with specific language impairment.

Paul J Yoder1, Dennis Molfese, Elizabeth Gardner.   

Abstract

PURPOSE: We sought to confirm predictions based on past findings that pretreatment mean length of utterance (MLU) would predict which of 2 grammatical treatments would best facilitate generalized and maintained grammatical development in preschoolers with specific language impairment (SLI).
METHOD: The participants were 57 preschoolers with SLI. A randomized group experiment was used. The 2 grammatical treatments were broad target recasts (BTR) and milieu language teaching (MLT). MLU was assessed at Time 1 in 2 conversational language samples. Growth rate of productive grammar was quantified using growth curve modeling on the Index of Productive Syntax (IPSyn) from 2 conversational language samples at each of 6 measurement periods.
RESULTS: Predictions were confirmed for children with initially low MLU but not for children with initially high MLUs. MLT facilitated growth of grammar better than BTR in children who were initially in Brown's stage I. Effects maintained 5 months after treatment ended.

Entities:  

Mesh:

Year:  2011        PMID: 21386042      PMCID: PMC3137743          DOI: 10.1044/1092-4388(2010/09-0246)

Source DB:  PubMed          Journal:  J Speech Lang Hear Res        ISSN: 1092-4388            Impact factor:   2.297


  9 in total

Review 1.  Mediators and moderators of treatment effects in randomized clinical trials.

Authors:  Helena Chmura Kraemer; G Terence Wilson; Christopher G Fairburn; W Stewart Agras
Journal:  Arch Gen Psychiatry       Date:  2002-10

Review 2.  Identifying predictors of treatment response.

Authors:  Paul Yoder; Don Compton
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2004

3.  How and why criteria defining moderators and mediators differ between the Baron & Kenny and MacArthur approaches.

Authors:  Helena Chmura Kraemer; Michaela Kiernan; Marilyn Essex; David J Kupfer
Journal:  Health Psychol       Date:  2008-03       Impact factor: 4.267

4.  Comprehension and production in early language development [see comment].

Authors:  E Bates
Journal:  Monogr Soc Res Child Dev       Date:  1993

5.  Comparison of conversational-recasting and imitative procedures for training grammatical structures in children with specific language impairment.

Authors:  S M Camarata; K E Nelson; M N Camarata
Journal:  J Speech Hear Res       Date:  1994-12

6.  What Does Teaching Declaratives Tell Us About the Criteria by Which we Can Judge the Developmental Importance of Treatment Outcomes?

Authors:  Paul Yoder; Rebecca Lieberman
Journal:  Evid Based Commun Assess Interv       Date:  2010-12

7.  The efficacy of treatment for children with developmental speech and language delay/disorder: a meta-analysis.

Authors:  James Law; Zoe Garrett; Chad Nye
Journal:  J Speech Lang Hear Res       Date:  2004-08       Impact factor: 2.297

8.  The relation between age and mean length of utterance in morphemes.

Authors:  J F Miller; R S Chapman
Journal:  J Speech Hear Res       Date:  1981-06

9.  The acquisition of tense and agreement morphemes by children with specific language impairment during intervention: phase 3.

Authors:  Laurence B Leonard; Stephen M Camarata; Monika Pawlowska; Barbara Brown; Mary N Camarata
Journal:  J Speech Lang Hear Res       Date:  2008-02       Impact factor: 2.297

  9 in total
  14 in total

1.  Using Computerized Language Analysis to Evaluate Grammatical Skills.

Authors:  Lizbeth H Finestack; Bobbi Rohwer; Lisa Hilliard; Leonard Abbeduto
Journal:  Lang Speech Hear Serv Sch       Date:  2020-04-07       Impact factor: 2.983

2.  Individual Versus Small Group Treatment of Morphological Errors for Children With Developmental Language Disorder.

Authors:  Sunniva S Eidsvåg; Elena Plante; Trianna Oglivie; Chelsea Privette; Marja-Liisa Mailend
Journal:  Lang Speech Hear Serv Sch       Date:  2019-04-23       Impact factor: 2.983

Review 3.  The efficacy of recasts in language intervention: a systematic review and meta-analysis.

Authors:  Patricia L Cleave; Stephanie D Becker; Maura K Curran; Amanda J Owen Van Horne; Marc E Fey
Journal:  Am J Speech Lang Pathol       Date:  2015-05       Impact factor: 2.408

4.  Predicting Language in Children with ASD Using Spontaneous Language Samples and Standardized Measures.

Authors:  Rebecca P Thomas; Kacie Wittke; Jessica Blume; Ann M Mastergeorge; Letitia Naigles
Journal:  J Autism Dev Disord       Date:  2022-08-05

5.  Normative topographic ERP analyses of speed of speech processing and grammar before and after grammatical treatment.

Authors:  Paul J Yoder; Dennis Molfese; Micah M Murray; Alexandra P F Key
Journal:  Dev Neuropsychol       Date:  2013       Impact factor: 2.253

6.  Feasibility of a Recasting and Auditory Bombardment Treatment With Young Cochlear Implant Users.

Authors:  Danielle Encinas; Elena Plante
Journal:  Lang Speech Hear Serv Sch       Date:  2016-04-01       Impact factor: 2.983

7.  An Open Conversation on Using Eye-Gaze Methods in Studies of Neurodevelopmental Disorders.

Authors:  Courtney E Venker; Sara T Kover
Journal:  J Speech Lang Hear Res       Date:  2015-12       Impact factor: 2.297

8.  Grammatical treatment and specific language impairment: neighbourhood density & third person singular -s.

Authors:  Jill R Hoover; Holly L Storkel
Journal:  Clin Linguist Phon       Date:  2013-07-02       Impact factor: 1.346

9.  Development of an expressive language sampling procedure in fragile X syndrome: a pilot study.

Authors:  Elizabeth Berry-Kravis; Emily Doll; Audra Sterling; Sara T Kover; Susen M Schroeder; Shaguna Mathur; Leonard Abbeduto
Journal:  J Dev Behav Pediatr       Date:  2013-05       Impact factor: 2.225

10.  Predictors of Treatment Response for Preschool Children With Developmental Language Disorder.

Authors:  Leah L Kapa; Christina Meyers-Denman; Elena Plante; Kevin Doubleday
Journal:  Am J Speech Lang Pathol       Date:  2020-09-30       Impact factor: 2.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.